par Woff, Erwin ;Hendlisz, Alain ;Ameye, Lieveke;Garcia, Camilo ;Kamoun, Tarek ;Guiot, Thomas ;Paesmans, Marianne ;Flamen, Patrick
Référence The Journal of nuclear medicine, 60, 2, page (178-184)
Publication Publié, 2019-02-01
Référence The Journal of nuclear medicine, 60, 2, page (178-184)
Publication Publié, 2019-02-01
Article révisé par les pairs
Titre: |
|
Auteur: | Woff, Erwin; Hendlisz, Alain; Ameye, Lieveke; Garcia, Camilo; Kamoun, Tarek; Guiot, Thomas; Paesmans, Marianne; Flamen, Patrick |
Informations sur la publication: | The Journal of nuclear medicine, 60, 2, page (178-184) |
Statut de publication: | Publié, 2019-02-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | FDG PET/CT |
Oncology: GI | |
PET/CT | |
metabolic active tumor volume | |
metastatic colorectal cancer | |
multikinase inhibitors | |
total lesion glycolysis | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Biomarkers -- metabolism | |
Colonic Neoplasms -- diagnostic imaging -- drug therapy -- metabolism -- pathology | |
Female | |
Fluorodeoxyglucose F18 | |
Glycolysis -- drug effects | |
Humans | |
Male | |
Middle Aged | |
Neoplasm Metastasis | |
Positron Emission Tomography Computed Tomography | |
Prognosis | |
Protein Kinase Inhibitors -- pharmacology -- therapeutic use | |
Retrospective Studies | |
Survival Analysis | |
Treatment Failure | |
Tumor Burden -- drug effects | |
Langue: | Anglais |
Identificateurs: | urn:issn:0161-5505 |
info:doi/10.2967/jnumed.118.210161 | |
info:pii/jnumed.118.210161 | |
info:pmid/29959212 |